190 related articles for article (PubMed ID: 18628788)
1. Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations.
Tabolacci E; Moscato U; Zalfa F; Bagni C; Chiurazzi P; Neri G
Eur J Hum Genet; 2008 Dec; 16(12):1487-98. PubMed ID: 18628788
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
3. Methylated premutation of the FMR1 gene in three sisters: correlating CGG expansion and epigenetic inactivation.
Tabolacci E; Pomponi MG; Remondini L; Pietrobono R; Nobile V; Pennacchio G; Gurrieri F; Neri G; Genuardi M; Chiurazzi P
Eur J Hum Genet; 2020 May; 28(5):567-575. PubMed ID: 31804632
[TBL] [Abstract][Full Text] [Related]
4. Role of CTCF protein in regulating FMR1 locus transcription.
Lanni S; Goracci M; Borrelli L; Mancano G; Chiurazzi P; Moscato U; Ferrè F; Helmer-Citterich M; Tabolacci E; Neri G
PLoS Genet; 2013; 9(7):e1003601. PubMed ID: 23874213
[TBL] [Abstract][Full Text] [Related]
5. CGG-repeat dynamics and
Zhou Y; Kumari D; Sciascia N; Usdin K
Mol Autism; 2016; 7():42. PubMed ID: 27713816
[TBL] [Abstract][Full Text] [Related]
6. Unstable mutations in the FMR1 gene and the phenotypes.
Loesch D; Hagerman R
Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306
[TBL] [Abstract][Full Text] [Related]
7. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program.
Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE
Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics of fragile X syndrome and fragile X-related disorders.
Kraan CM; Godler DE; Amor DJ
Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.
Todd PK; Oh SY; Krans A; Pandey UB; Di Prospero NA; Min KT; Taylor JP; Paulson HL
PLoS Genet; 2010 Dec; 6(12):e1001240. PubMed ID: 21170301
[TBL] [Abstract][Full Text] [Related]
10. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
[TBL] [Abstract][Full Text] [Related]
11. Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene.
Nobile V; Palumbo F; Lanni S; Ghisio V; Vitali A; Castagnola M; Marzano V; Maulucci G; De Angelis C; De Spirito M; Pacini L; D'Andrea L; Ragno R; Stazi G; Valente S; Mai A; Chiurazzi P; Genuardi M; Neri G; Tabolacci E
Hum Genet; 2020 Feb; 139(2):227-245. PubMed ID: 31919630
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation, Mechanisms of
Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel epigenetic marker for typical and mosaic presentations of Fragile X syndrome.
da Silva CP; Camuzi D; Reis AHO; Gonçalves AP; Dos Santos JM; Machado FB; Medina-Acosta E; Soares-Lima SC; Santos-Rebouças CB
Expert Rev Mol Diagn; 2023; 23(12):1273-1281. PubMed ID: 37970883
[TBL] [Abstract][Full Text] [Related]
14. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.
Tabolacci E; Pietrobono R; Moscato U; Oostra BA; Chiurazzi P; Neri G
Eur J Hum Genet; 2005 May; 13(5):641-8. PubMed ID: 15741991
[TBL] [Abstract][Full Text] [Related]
15. A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome.
Dahl C; Grønskov K; Larsen LA; Guldberg P; Brøndum-Nielsen K
Clin Chem; 2007 Apr; 53(4):790-3. PubMed ID: 17259243
[TBL] [Abstract][Full Text] [Related]
16. Unmethylated Mosaic Full Mutation Males without Fragile X Syndrome.
Tak Y; Schneider A; Santos E; Randol JL; Tassone F; Hagerman P; Hagerman RJ
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540390
[TBL] [Abstract][Full Text] [Related]
17. CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.
Pretto DI; Mendoza-Morales G; Lo J; Cao R; Hadd A; Latham GJ; Durbin-Johnson B; Hagerman R; Tassone F
J Med Genet; 2014 May; 51(5):309-18. PubMed ID: 24591415
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics, fragile X syndrome and transcriptional therapy.
Tabolacci E; Chiurazzi P
Am J Med Genet A; 2013 Nov; 161A(11):2797-808. PubMed ID: 24123753
[TBL] [Abstract][Full Text] [Related]
19. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
[TBL] [Abstract][Full Text] [Related]
20. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.
Godler DE; Tassone F; Loesch DZ; Taylor AK; Gehling F; Hagerman RJ; Burgess T; Ganesamoorthy D; Hennerich D; Gordon L; Evans A; Choo KH; Slater HR
Hum Mol Genet; 2010 Apr; 19(8):1618-32. PubMed ID: 20118148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
